Loading organizations...
Cell-based therapeutics for regenerative medicine and immuno-oncology.
HebeCell has raised $53.0M across 1 funding round.
HebeCell has raised $53.0M in total across 1 funding round.
HebeCell has raised $53.0M in total across 1 funding round.
HebeCell's investors include Yinxiang Wang.
HebeCell has raised $53.0M across 1 funding round. Most recently, it raised $53.0M Series A in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 31, 2021 | $53.0M Series A | Yinxiang Wang |